Sector News

ChemChina, Syngenta publish timetable and prospectus for takeover offer

March 8, 2016
Chemical Value Chain

A prospectus issued by ChemChina (Beijing) and Syngenta (Basel) on Tuesday provides more details on the proposed $43 billion acquisition of the leading global agricultural chemicals group by ChemChina.

The prospectus, issued a week earlier than expected, states that the takeover offer is set to commence on 23 March and run until 23 May, if not extended. The Swiss public tender offer will be open for an initial period of 40 trading days and may be renewed once or several times for subsequent periods of up to 40 trading days, pending satisfaction of all offer conditions, including receipt of all regulatory approvals. ChemChina intends to align the timelines of the US offer with those of the Swiss offer, and the whole transaction is expected to close by the end of 2016.

Syngenta’s break fee–the amount payable to ChemChina if the deal is terminated at Syngenta’s request–has been reduced from $1.5 billion to $848 million, as agreed between the Swiss Takeover Board and ChemChina. ChemChina would have to pay a $3 billion reverse break fee, as previously agreed, unless Syngenta is forced to divest more than $2.68 billion or 20% of sales, to resolve antitrust and CFIUS (the Committee on Foreign Investment in the US) issues; or ChemChina loses control of more than $1.54 billion sales to resolve CFIUS-related concerns.

The prospectus says ChemChina has secured full financing and could replace part or all by equity funds from its own resources and several third parties. The prospectus does not provide a timeline for an initial public offering of Syngenta’s shares but says that ChemChina would float a portion of Syngenta’s shares over “the next years.”

ChemChina has agreed to several governance provisions that will remain in place until the earlier of (1) five years following the first settlement date of the offer and (2) the relisting of Syngenta shares through an IPO. During this period, there will be four directors unaffiliated to ChemChina on the 10-member Syngenta board. At least two of these independent directors would have to approve specified major changes, including any change of location of Syngenta’s headquarters and any reduction of the R&D budget in any given year to a level below 80% of the average R&D spend in the years 2012-15.

In addition to its own advisors Goldman Sachs and J.P. Morgan, Syngenta mandated N+1 Swiss Capital, a Swiss corporate finance advisory firm, to issue a fairness opinion on the offer. This company determined a valuation range of 400.61-464.55 Swiss francs per Syngenta share, and thus concluded that the ChemChina offer price, equivalent to SF480 per share, was fair and adequate.

In the event of a third party intervening, ChemChina would have at least five trading days to respond to a higher offer.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

January 29, 2023

Dow and 3M cut thousands of jobs

Chemical Value Chain

3M and Dow have announced they are cutting thousands of roles from their global workforces in response to economic pressures. Dow has said it will cut 2,000 jobs across its global workforce (around 5%) in a bid to save US$1bn in 2023. The company says it will also cut costs by shutting down “select assets”, though it did not note where it would halt operations.

January 29, 2023

Sweden discovers Europe’s largest rare earths deposit

Chemical Value Chain

Sweden’s state mining firm has discovered what could be Europe’s largest rare earths deposit, and says it could help the bloc reduce its reliance on imports of minerals needed to manufacture clean technologies and meet climate targets.

January 29, 2023

Avantium to supply Henkel with plant-based FDCA

Chemical Value Chain

Henkel and Avantium have been partners since 2019, when Henkel joined the PEFerence consortium. This consortium of partners, coordinated by Avantium, aims to establish an innovative supply chain for FDCA and PEF (polyethylene furanoate).

How can we help you?

We're easy to reach